BioCorporate profile downloaded from - http://www.bioportfolio.

com on Wednesday, July 15, 2009

Biozyme Laboratories International Limited

View the current Biozyme Laboratories International Limited Page on BioPortfolio.com (http://www.bioportfolio.com/biocorporate/19983-Biozyme+Laboratories+International+Limited.html)

Contact Details: 9939 Hibert Street, Suite 101, San Diego California 92131-1029 United States of America

Tel: (858) 549 4484 or (800) 423 8199 Fax: (858) 549 0138 Email: Bioinfo@biozyme.com Sales@biozyme.com

Our mission is to continue to establish Biozyme as a world leader in the supply of high quality biochemicals to the medical diagnostics and healthcare industries through excellence in customer service. We specialise in the development and bulk manufacture of high purity enzymes and proteins. Biozyme's products are highly regarded by many of the world's leading in vitro diagnostic (IVD) kit manufacturers. Our current product range consists of approximately 80 enzymes, many of which are available in a variety of grades to suit particular applications. Biozyme's wealth of expertise is now being applied to the manufacture of certain enzymes to active pharmaceutical intermediate (API) status for incorporation into Biopharmaceuticals. As a valued supplier to many blue chip companies, Biozyme prides itself in providing the highest possible standards of quality and customer service. The Quality Management Systems of our UK operation, which consists of two manufacturing facilities, have been certified as meeting the requirements of ISO 9001:2000 by SGS Yarsley ICS Limited.We also have a sales and marketing office based in San Diego, California and a world-wide network of distributors who work closely with our U.K. technical personnel. This ensures a rapid response to your enquiries and demonstrates our commitment to building and maintaining close relationships with both existing and new clients throughout the world

BioNews Results for Biozyme Laboratories International Limited

FDA Takes Enforcement Action Against Three New Jersey Dietary Supplement and Protein Powder Manufacturers HealthNewsDigest.com: Jul 11 2009 7:46PM Matching: laboratories international CRA International Announces Changes To Its Board Of Directors NewsBlaze: Jul 11 2009 2:59AM Matching: laboratories international Charles River Schedules Second-Quarter 2009 Earnings Release and Conference Call Pharma Live: Jul 10 2009 4:19PM Matching: laboratories international Stocks with strong dividend histories, prospects

1/3

NOLA Live: Jul 10 2009 12:05AM Matching: laboratories international Charles River Laboratories (Massachusetts) Schedules Second-Quarter 2009 Earnings Release and Conference Call BioSpace: Jul 9 2009 8:32PM Matching: laboratories international Charles River Schedules Second-Quarter 2009 Earnings Release and Conference Call NewsBlaze: Jul 9 2009 3:28PM Matching: laboratories international Charles River Schedules Second-Quarter 2009 Earnings Release and Conference Call Genetic Engineering News: Jul 9 2009 2:26PM Matching: laboratories international Abbott Wins Appeal on Norvir Antitrust Case AIDSmeds: Jul 9 2009 8:31PM Matching: laboratories international Abbott Wins Appeal on Norvir Antitrust Case POZ.com: Jul 8 2009 10:44PM Matching: laboratories international OncQuest Labs launches K-RAS Mutation Analysis for diagnosis of colorectal & lung cancers PharmaBiz: Jul 3 2009 4:18AM Matching: laboratories international One Health-Care Fund That's on the Mend Smart Money: Jul 2 2009 7:37PM Matching: laboratories international Pharmaceutical Development Services Establishes U.S. Base For Expansion Pharmaceutical Online: Jul 2 2009 9:10AM Matching: laboratories international Charles River Laboratories (Massachusetts) Announces RMS Succession Plan and Organizational Enhancements BioSpace: Jul 1 2009 5:47PM Matching: laboratories international Allied Healthcare International Inc. Elects Dr. Jeffrey S. Peris as Non-Executive Chairman of the Board Market Wire: Jul 1 2009 2:49PM Matching: laboratories international Allied Healthcare International Inc. Elects Dr. Jeffrey S. Peris as Non-Executive Chairman of the Board Marketwire via Yahoo!: Jul 1 2009 2:55PM Matching: laboratories international

BioCorporate Profiles - upgrade to a full profile

BioPortfolio's BioCorporate full profiles offers your organization the opportunity to increase internet traffic to your corporate web site and enhance awareness of your business, technology, products and services. BioCorporate profiles are dynamic and are updated weekly with new information sourced from core information resources: publications, clinical trials, patents and global news. Why you should upgrade your BioPortfolio BioCorporate profile: the ability to amend and add information on products and services to your profile using a membership username and password the option to add a corporate logo the creation of high value URL links back to your organization's website which will improve search engine ranking - resulting in increased site traffic the option have your press releases published on BioPortfolio and distributed via our BioNewsCast service an enhanced BioCororporate profile will also improve your exposure on BioPortfolio's related service InDepth and GeneDB

The annual cost is $995.00 for established organizations and $495.00 for organizations less than 12 months old.

***

2/3

Resources from the NCBI used in this document, NCBI's standard disclaimer applies. Nothing in this document should be used in place of personal medical advice from your own qualified medical practitioner. See BioPortfolio.com User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472 Peter Barfoot peter.barfoot@bioportfolio.com All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Stafford House, 10 Prince of Wales Road, Dorchester, Dorset, DT1 1PW, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2009 - BioPortfolio Limited.

3/3